Watson launches generic Biaxin XL drug |
|
|
|
Published
:
Thu, 03 Jan 2008 16:37
|
CORONA, Calif. (AP) - Specialty pharmaceutical company Watson Pharmaceuticals Inc. launched a generic tablet Thursday aimed at treating or preventing bacterial infections.The company's new 500-mg Clarithromycin Extended-Release tablets are a generic version of Abbott Laboratories' Biaxin XL.Biaxin XL and generic versions of the antibiotic had about $200 million in sales for the year ended September 2007.Watson received Food and Drug Administration approval for its generic tablet on June 24, 2004.Watson's tablet was then tied up in a patent-infringement lawsuit filed by Abbott. The lawsuit was dismissed on July 12, 2007, with prejudice, meaning the complaint can't be refiled.Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Watson Pharma, Novartis settle suit 